ResearcherUniversity of Maryland, BaltimoreActive in the last 2 years

Deborah de la Caridad Delgado Herrera

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0008-5654-4863; OpenAlex author ID A5101328906. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2026: 2 papers

Papers 2

GSTT1 promotes stemness and FGFR inhibitor sensitivity in pancreatic cancer through regulation of CD133 (PROM1). Co-author DOI 10.1016/j.canlet.2026.218733 ↗
KRAS on Empty: Lipid Oxidation Blockade Reveals a Metabolic Achilles' Heel in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-25-1877 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Christina Ferrer · 2 shared papers, 2026 · strength 0.93
- Paper KRAS on Empty: Lipid Oxidation Blockade Reveals a Metabolic Achilles' Heel in Pancreatic Cancer. DOI 10.1158/0008-5472.can-25-1877 ↗
- Paper GSTT1 promotes stemness and FGFR inhibitor sensitivity in pancreatic cancer through regulation of CD133 (PROM1). DOI 10.1016/j.canlet.2026.218733 ↗
Elana Judith Fertig · 1 shared paper, 2026 · strength 0.30
- Paper GSTT1 promotes stemness and FGFR inhibitor sensitivity in pancreatic cancer through regulation of CD133 (PROM1). DOI 10.1016/j.canlet.2026.218733 ↗
Emily L. Lasse Opsahl · 1 shared paper, 2026 · strength 0.30
- Paper GSTT1 promotes stemness and FGFR inhibitor sensitivity in pancreatic cancer through regulation of CD133 (PROM1). DOI 10.1016/j.canlet.2026.218733 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.